| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038608158 |
| P356 | DOI | 10.1007/BF03086253 |
| P932 | PMC publication ID | 2711248 |
| P698 | PubMed publication ID | 19789685 |
| P2093 | author name string | van den Berg MP | |
| Zijlstra JG | |||
| Tulleken JE | |||
| Aarts LP | |||
| Slart RH | |||
| Meijer PM | |||
| Wijkstra PJ | |||
| van Bockel EA | |||
| Lind JS | |||
| P2860 | cites work | Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy | Q80859038 |
| Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 | ||
| The heart in human dystrophinopathies | Q35067344 | ||
| BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases | Q35987052 | ||
| Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? | Q37353603 | ||
| Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy | Q40216140 | ||
| Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy | Q43485888 | ||
| Assessment of cardiac function in adolescents with Duchenne muscular dystrophy: importance of neurohormones | Q44003591 | ||
| Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy | Q46377870 | ||
| Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy | Q46577617 | ||
| Cardioprotection for Duchenne's muscular dystrophy | Q48224419 | ||
| B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy | Q48381296 | ||
| Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy | Q48664793 | ||
| Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy | Q48668926 | ||
| A comparison between MUGA and echocardiography in patients with muscular dystrophy in the early detection of cardiac involvement. | Q50892617 | ||
| 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. | Q53304609 | ||
| ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199 | Q73904936 | ||
| Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy | Q77808613 | ||
| Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy | Q78005705 | ||
| Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients | Q79999272 | ||
| The feasibility of repeated left ventricular ejection fraction analysis with sequential single-dose radionuclide ventriculography | Q80341690 | ||
| A new lease on life for patients with Duchenne muscular dystrophy in Japan | Q80506976 | ||
| P433 | issue | 6 | |
| P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
| P304 | page(s) | 232-237 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Netherlands Heart Journal | Q2146163 |
| P1476 | title | Cardiac assessment of patients with late stage Duchenne muscular dystrophy | |
| P478 | volume | 17 |
| Q34840485 | Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers |
| Q57061444 | Cardiac Management of the Patient With Duchenne Muscular Dystrophy |
| Q38204281 | Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy |
| Q37889770 | Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions |
| Q89425577 | Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy |
| Q33844719 | Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy |
| Q34508301 | Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease |
| Q30377707 | Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies. |
| Q51164233 | Low dystrophin levels in heart can delay heart failure in mdx mice. |
| Q36674598 | Mapping contrast agent uptake and retention in MRI studies of myocardial perfusion: case control study of dogs with Duchenne muscular dystrophy |
| Q37864597 | N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin |
| Q99558319 | Sudden cardiac death of Duchenne muscular dystrophy with NT-proBNP in pericardial fluid as a useful biomarker for diagnosis of the cause of death: a case report |
| Q92803183 | The Relationship between Preoperative Echocardiographic Evaluation and Spinal Deformity in Patients with Neuromuscular Scoliosis |
Search more.